Featured articles

Trends in Therapeutic Monoclonal Antibody Discovery Technology

David Meininger (Protein Sciences, Merck) argues that with a 2012 mAb market sales estimate of $50 billion, the relevant technology trends warrant careful consideration. Read more.

Too Much Testing?

Vivian Lindo (Associate Director, MedImmune) questions the balance between obtaining useful characterisation data and simply testing too much. Read more.

Antibodies as Tools in Small Molecule Drug Discovery

Alastair Lawson (Structural Biology, UCB) reviews the role of antibodies and intrabodies in the early phases of drug discovery. Read more.

ImmunoGen’s TAP Technology Shows Positive Clinical Results

T-DM1 significantly improved progression-free survival compared to standard of care for previously untreated HER2-positive metastatic breast cancer. Read more.

The EC FP7 ComplexINC project: New Technologies and Production Tools for Complex Protein Biologics

The ComplexINC consortium, a four year collaborative project funded by the EC, aims to roll out new technologies for the production of complex biologics. Read more

Biomedical Applications of Octapeptide Gels

Researchers at Manchester University show the potential of octapeptide hydrogels as injectable scaffolds for therapeutic application. Read more

Antibody Discovery Advanced Platform Technologies

Scientists at Xoma have developed technologies to allow seamless integration between phage, yeast and mammalian display. Read more.

Human scFv Antibody Generation Pipeline – from Proteome Research to Biomedical Application

Researchers at TUB investigate the potential of antibody generation platforms for applications beyond research. Read more.